2026-03-09T16:49:27-05:00 2025-06-30 814234542 BPM LLP 10 ALMADEN BOULEVARD SUITE 1000 SAN JOSE CA 951132238 990 2024-07-01 453266802 CANCER COMMONS CANC 6502894044 2625 MIDDLEFIELD ROAD 104 PALO ALTO CA 94306 SHELLEY FRISBIE CFO 6502894044 2026-03-09 1 1 TAMARA L MCINERNEY P00011797 4089616300 2026-03-09 2024 2025-03-06 01:10:19Z JAY M TENENBAUM 2625 MIDDLEFIELD ROAD 104 PALO ALTO CA 94306 2077981 0 X WWW.CANCERCOMMONS.ORG X 2011 CA CANCER COMMONS IS A NONPROFIT THAT PROVIDES PATIENTS, CAREGIVERS, AND TREATING PHYSICIANS WITH ACTIONABLE INFORMATION TO SUPPORT INFORMED TREATMENT DECISIONS, ALONG WITH DIRECT-TO-PATIENT NAVIGATION SERVICES FOR INDIVIDUALS WITH CANCER AND THEIR CAREGIVERS. THE ORGANIZATION WORKS TO ENSURE THAT EVERY PERSON FACING CANCER CAN ACCESS EXPERT GUIDANCE, PERSONALIZED INSIGHTS, AND THE MOST PROMISING TREATMENT OPTIONS, REGARDLESS OF WHERE THEY LIVE OR THEIR ABILITY TO PAY. 7 6 6 4 0 0 1247340 1794845 0 25000 -653 23137 0 0 1246687 1842982 0 0 0 0 708604 1062838 0 30000 175873 462832 633645 1171436 1726483 75251 116499 517762 668478 90912 125129 426850 543349 X CANCER COMMONS IS A NONPROFIT THAT PROVIDES PATIENTS, CAREGIVERS, AND TREATING PHYSICIANS WITH ACTIONABLE INFORMATION TO SUPPORT INFORMED TREATMENT DECISIONS, ALONG WITH DIRECT-TO-PATIENT NAVIGATION SERVICES FOR INDIVIDUALS WITH CANCER AND THEIR CAREGIVERS. 0 0 809763 PATIENT NAVIGATION AND SUPPORT:CANCER COMMONS PROVIDED PERSONALIZED NAVIGATION AND EXPERT GUIDANCE TO APPROXIMATELY 1,200 NEW AND RETURNING CLIENTS DURING THE YEAR ENDED JUNE 30, 2025. MANY OF THESE INDIVIDUALS FACED ADVANCED OR HARD-TO-TREAT CANCERS, INCLUDING BRAIN AND PANCREATIC CANCERS, WHERE TREATMENT DECISIONS ARE COMPLEX AND TIME-SENSITIVE.THE ORGANIZATION'S SERVICES HELP PATIENTS AND CAREGIVERS UNDERSTAND THEIR DIAGNOSIS, CLARIFY TREATMENT GOALS, AND EVALUATE TESTING, THERAPIES, AND CLINICAL TRIALS. EACH PATIENT IS PAIRED WITH A SCIENTIST WHO REVIEWS MEDICAL HISTORY, RESEARCHES ADDITIONAL TESTING, AND IDENTIFIES POTENTIAL TREATMENT PATHS AND TRIAL OPPORTUNITIES. THIS INDIVIDUALIZED SUPPORT EMPOWERS PATIENTS TO MAKE INFORMED DECISIONS AT CRITICAL MOMENTS IN THEIR CARE AND HELPS FAMILIES NAVIGATE AN OVERWHELMING AND RAPIDLY EVOLVING MEDICAL LANDSCAPE. DONOR SUPPORT ENABLES CANCER COMMONS TO PROVIDE THESE SERVICES AT NO COST TO PATIENTS. 298783 LEARNING HEALTH SYSTEM DEVELOPMENT:CANCER COMMONS CONTINUED DEVELOPMENT ON THE LEARNING HEALTH SYSTEM (LHS), A TECHNOLOGY PLATFORM DESIGNED TO ACCELERATE AND IMPROVE TREATMENT DECISION-MAKING FOR PATIENTS WITH ADVANCED CANCERS. THE SYSTEM INTEGRATES REAL-WORLD PATIENT DATA AND AI-DRIVEN ANALYSIS TO HELP IDENTIFY PROMISING TREATMENT OPTIONS AND REFINE RECOMMENDATIONS OVER TIME. THIS WORK ADVANCES THE ORGANIZATION'S LONG-TERM VISION: A LEARNING HEALTH SYSTEM IN WHICH EACH PATIENT'S EXPERIENCE CONTRIBUTES TO KNOWLEDGE THAT BENEFITS THE NEXT. DONOR INVESTMENT IN THIS INITIATIVE HELPS BUILD A FUTURE WHERE PERSONALIZED, DATA-INFORMED CANCER CARE IS ACCESSIBLE TO ALL. 133290 WEBSITE, MARKETING, AND COMMUNICATIONS:THE ORGANIZATION ADVANCED ITS WEBSITE, MARKETING, AND COMMUNICATIONS INITIATIVES TO SUPPORT AN UPDATED BRAND IDENTITY AND IMPROVE ACCESS TO PATIENT-FACING RESOURCES. DURING THE YEAR, CANCER COMMONS COMPLETED FOUNDATIONAL WORK, INCLUDING CONTENT DEVELOPMENT, DESIGN PLANNING, AND USER-EXPERIENCE IMPROVEMENTS THAT WILL ENABLE A FULL LAUNCH IN THE FOLLOWING FISCAL YEAR. THESE EFFORTS STRENGTHEN THE ORGANIZATION'S ABILITY TO REACH PATIENTS AND CAREGIVERS SEEKING TIMELY, TRUSTWORTHY GUIDANCE. 127653 PARTNERSHIPS:CANCER COMMONS COLLABORATES WITH MISSION-ALIGNED PARTNERS TO EXTEND EXPERT GUIDANCE TO PATIENTS WHO NEED IT MOST. THESE PARTNERSHIPS STRENGTHEN THE ORGANIZATION'S REACH AND ENSURE THAT INDIVIDUALS REFERRED BY TRUSTED INSTITUTIONS RECEIVE TIMELY, PERSONALIZED SUPPORT.KEY PARTNERSHIPS INCLUDED THE MUSELLA FOUNDATION FOR BRAIN TUMOR RESEARCH & INFORMATION AND HEAD FOR THE CURE, WHICH JOINTLY PROVIDED GRANT FUNDING TO EXPAND BRAIN CANCER NAVIGATION SERVICES. THIS SUPPORT ENABLED THE ORGANIZATION TO ENGAGE AN ONCOLOGY NURSE NAVIGATOR AND OFFER SPECIALIZED GUIDANCE TO BRAIN TUMOR PATIENTS AND CAREGIVERS. THROUGH THESE COLLABORATIONS, CANCER COMMONS REACHED MORE FAMILIES CONFRONTING SOME OF THE MOST CHALLENGING CANCER DIAGNOSES AND ENSURED THEY HAD ACCESS TO EXPERT, COMPASSIONATE SUPPORT. 127653 1369489 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 13 0 1 6 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X X THE ORGANIZATION 6505303636 2625 MIDDLEFIELD ROAD SUITE 104 PALO ALTO CA 94306 JAY M TENENBAUM FOUNDER AND CHAIRMAN 20.00 X X 0 0 0 PAUL BILLINGS VICE CHAIR AND ACTING CEO 1.00 X X 20000 0 0 LARRY MARTON BOARD MEMBER 1.00 X 0 0 0 VERN NORVIEL BOARD MEMBER 1.00 X 0 0 0 GREG SIMON BOARD MEMBER 1.00 X 0 0 0 BILL STASIOR BOARD MEMBER 1.00 X 0 0 0 DON MORRISON BOARD MEMBER (FROM 2/27/25) 1.00 X 0 0 0 SHELLEY FRISBIE CFO 25.00 X 58500 0 0 ADRIENNE NUGENT CHIEF OPERATING OFFICER 40.00 X 170000 0 180 MASAKO YOKOTA DIRECTOR, OFFICE OF THE CHAIRMAN 40.00 X 112000 0 2194 SUNEETA MANDAVA SENIOR CLINICAL ONCOLOGY SCIENTIST 40.00 X 148000 0 18819 508500 0 21193 3 0 1 0 ALAN LITTLEFORD 977 CROOKED CREEK DRIVE LOS ALTOS CA 94024 CONSULTING AND TECHNICAL SERVICES 133250 1 1794845 245153 1794845 PROGRAM SERVICE FEES 900099 25000 25000 25000 18465 18465 239671 234999 4672 4672 4672 1842982 25000 0 23137 X 276052 236635 14043 25374 653308 560008 33249 60051 73724 65673 1294 6757 59754 54296 1793 3665 39040 5856 26067 7117 30000 30000 539253 430912 78086 30255 12043 2992 6940 2111 14760 5969 4972 3819 11258 742 3792 6724 15697 6406 9291 HOLIDAY EVENT AND GIFTS 1135 1135 LATE FEES & PENALITIES 254 254 TAXES & LICENSES 205 205 1726483 1369489 181121 175873 498835 351483 6000 295410 10927 19585 1196 1196 0 0 2000 2000 517762 668478 90912 125129 90912 125129 X 166850 495849 260000 47500 426850 543349 517762 668478 116499 0 X 0 1 X 0 0 X 1733265 1629264 1170687 1247340 1794845 7575401 1733265 1629264 1170687 1247340 1794845 7575401 2631760 4943641 361 24 3146 18465 21996 6329 6329 7603726 109553 0.65020 0.63340 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1196 1196 0 0 2000794 157812 157812 1842982 0 1842982 1884295 157812 157812 1726483 0 1726483 X 1 ELLEN BECK PO BOX 596 OTIS MA 01253 RAISING FUNDS FROM THE PUBLIC SECTOR 0 0 60000 0 60000 X X X 0 0 0 0 0 0 0 0 0 ADRIENNE NUGENT CHIEF OPERATING OFFICER 170000 0 0 0 0 0 0 0 180 0 170180 0 0 0 SUNEETA MANDAVA SENIOR CLINICAL ONCOLOGY SCIENTIST 148000 0 0 0 0 0 0 0 18819 0 166819 0 0 0 PAUL BILLINGS VICE CHAIR 81665 CONSULTING SERVICES 0 SHELLEY FRISBIE CFO 80865 CONSULTING SERVICES 0 PART IV, LINE 1: PAUL BILLINGS, VICE CHAIR OF THE BOARD, PROVIDED CONSULTING SERVICES TO THE ORGANIZATION AND RECEIVED $81,665 IN COMPENSATION IN FISCAL YEAR ENDED JUNE 30, 2025.THE SHELLARD GROUP IS A C CORPORATION OWNED BY SHELLEY FRISBIE AND WAS ESTABLISHED IN DECEMBER 1985. CONSULTING COMPENSATION PAID TO THE SHELLARD GROUP FOR THE FISCAL YEAR ENDED JUNE 30, 2025 WAS $80,865. X 4 245153 FMV 0 0 0 PART I, COLUMN (B): THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS GIVEN TO THE GOVERNING BODY BEFORE THE RETURN IS FILED. THEY REVIEW AND CAN REQUEST CHANGES AT THIS TIME. FORM 990, PART VI, SECTION B, LINE 12C THE OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE REQUIRED TO REVIEW AND SIGN THE WRITTEN CONFLICT OF INTEREST POLICY ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS PERFORMS ALL INTERVIEWS SPECIFIC TO TOP KEY POSITIONS WHICH IS THEN FORWARDED TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER CONSULTING COSTS: PROGRAM SERVICE EXPENSES 430,912. MANAGEMENT AND GENERAL EXPENSES 78,086. FUNDRAISING EXPENSES 30,255. TOTAL EXPENSES 539,253.